07 November 2019
Visiongain has launched a new pharma report “Scanning Electron Microscopes Market Report 2020-2030” Prospects by Type (Scanning, Transmission), Application (Automobiles, Electronics & Semiconductors, Pharmaceuticals, Steel & other metals, Other applications) and Geography.
The global scanning electron microscopes market is projected to grow on account increasing demand of nanotechnology-based research, growing applications in semi-conductor, electronics & pharmaceutical industries among other contributing growth factors. The global market is projected to grow at a lucrative CAGR of ~10% over the forecast period 2020-2030 and anticipated to surpass USD 2 billion by 2020.
The scanning electron microscope (SEM) remains one of the most powerful and versatile tools used in research, development and production environments. The SEM is capable of imaging a wide range of sample types & sizes, often with nominal sample preparation, and is capable of generating multiple analytical signals, thus providing high-resolution information about a sample's composition, phase, electrical, optical, and other properties.
Key market drivers include increasing demand for nanotechnology-based research and the consequent growth in investments and funding from regional government bodies. Also, increasing applications in the semiconductors, electronic and pharmaceutical industries is expected to boost growth over the forecast period from 2020 to 2030.
Increasing global emphasis on R&D for applications such as neuroscience, material science, life science, nanotechnology, and semiconductor industry is anticipated to boost demand for adoption of advanced and automated microscopes such as analytical electron microscope, microscope scanning probe, and SEM. Such microscopes have image resolution as high as 0.1 nm, which is important for these manufacturing industries.
In terms of application, pharmaceutical dominated the global scanning electron microscope market in 2018 with over 35% of the global market share. Also, the growing burden of chronic diseases and other diseases in anticipated to boost further growth especially in the developing regions across the globe.
In the year 2018, Asia Pacific dominated the global scanning electron microscope market with over 35% of the global market share. The key factor that accounts for its significant share is rapid growth in applications such as semiconductors, pharmaceuticals, and nanotechnology among other applications.
North America is the second-largest market in terms of revenue owing to the presence of research and academic institutes and an increasing number of clinical studies across the United States. Research-based activities in the life sciences, biotechnology, and pharmaceutical industries are an important part of North American countries ' innovation system and this is anticipated to increase the regional demand for SEM over the forecast period.
Some of the major players operating in this industry are Angstrom Advanced Inc., Bruker Corporation, Carl Zeiss, Danish Micro Engineering (DME), FEI Company, Hirox Europe Ltd., Hitachi High Technologies Corporation, JEOL Ltd, Leica Microsystems, Nanoscience Instruments, Inc., Nikon Corporation, Olympus Corporation, Tescan Orsay Holding, Thermo Fisher Scientific., ADVANTEST, COXEM Co., Ltd., and GETec Microscopy GmbH among other prominent players.
Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to email@example.com or call her on +44 (0) 207 336 6100.
Visiongain is one of the fastest growing and most innovative independent media companies in Europe. Based in London, UK, Visiongain produces a host of business-to-business reports focusing on the automotive, aviation, chemicals, cyber, defence, energy, food & drink, materials, packaging, pharmaceutical and utilities sectors.
Visiongain publishes reports produced by analysts who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high-quality, original material to rely and depend on.
Rising preference for personalised medicine in developed as well developing economies coupled with increasing investment by biotechnological and pharmaceutical companies for drug discovery is expected to increase RNA analysis/transcriptomics market concentration over the forecast period. In order to increase the reliability and success rate of the drug production process.
30 November 2020
The market is forecasted for the next ten years based on market growth within each segment of the blood plasma products. The report study aims to explore the market drivers, restraints and also market opportunities facing blood plasma product stakeholders in different geographic areas.
26 November 2020
Molecular diagnostics are rapidly transforming drug development and patient selection: trials with biomarkers have higher success rates than those without, and combining patients with a proven biomarker allows efficient trials to be conducted in rare cancers.
26 November 2020
Growing demand for cost-effective drugs; rising prevalence of chronic diseases; mounting investment in drug R&D by biopharmaceutical companies; new product launches and rising acceptance of biosimilars in North America region are some of the major factors that propel the biosimilars market growth.